Abstract
The Food and Drug Administration (FDA) has few formal regulations applicable to pharmaceutical promotion, and lately has taken few publicly-available enforcement actions. This makes it challenging for companies to comply with FDA policies. Over the years, however, the agency has followed a few basic principles that apply to advertising and promotion. These include FDA's view that it has jurisdiction over all marketing activities; that “off-label” promotions are prohibited; and that claims must be fairly balanced and represent full disclosure. FDA should do a better job of explaining its policies and actions, but in the meantime, regulated companies can understand how to comply by understanding these basic principles.
Get full access to this article
View all access options for this article.
